STRATEGY, INVESTMENT AND PARTNERING FOR LIFE SCIENCE EXECUTIVES

2nd Annual Conference
October 7-8, 2019
Convene Convention Center
Boston | USA
#LSXUSA

Key Partners

Peer-to-peer knowledge exchange, curated group meetings, and content to address the questions on the minds of CEOs

LSX World Congress USA

What is it and who is it for?

The LSX World Congress USA is a gathering of the industries foremost life science executive leaders.

Now in it’s second year, LSX USA follows the unique style and format of the LSX World Congress in London focusing on strategy, investment and partnering.

The three core pillars of our community are:

CxOs of life sciences companies
Heads of Pharma Business Development
VC and PE Investors

We address and look to find solutions to the respective challenges they face, and connect them with strategies, solutions and contacts to enable growth and development in their businesses.

Confirmed Speakers

Ted Tanner Jr.

CTO & Chief Architect, Watson Health, IBM

Nigel Sheail

Global Head of M&A & Business Development & Licensing, Novarits

Rogerio Vivaldi

CEO, Sigilon Therapeutics

Ricky Sun

Partner, Life Sciences, Bain Capital

Todd Foley

Managing Partner, MPM Capital

Peter Dudek

Partner, MRL Ventures Fund

Priyanka Rohatgi

Managing Director, Head, Ipsen Ventures

Adam Houghton

VP & Head, AbbVie Ventures

Jay Stamatis

VP, Head of Business Development & Acquisitions, Abbvie

Nicole Kholodnov

VP of Clinical Operations, Parsley Health

Kelly Gold

VP, Corporate Development, CAMP4 Therapeutics

Dan Grau

CEO, Sojournix

Marshall Smith

Head of Global Healthcare, Goldman Sachs

Carolyn Witte

Co-Founder & CEO, Tia

Joel Wishkovsky

CEO, Simple Contacts

Adam Rosenberg

President & CEO, Rodin Therapeutics

Laurent Audoly

President & CEO, Kymera Therapeutics

Meredith Fisher

Partner, Partners Innovation Fund, Partners Healthcare

Veronique Riethuisen

SVP, Global Head of Business Development & Alliance Management, Ipsen

Melissa Fensterstock

Co-Founder & CEO, Landsdowne Labs

Agenda at a Glance

Forum - 7 October

09:00

1-2-1 Meetings

12:30

Lunch Break

13:30

Investor Forum

Early Stage CEO Forum

Growth Stage CEO Forum

Publicly Listed CEO Forum

17:30

Investor Drinks & Dinner

CEO Drinks & Dinner

Conference - 8th October

09:00

Keynote Plenary

1-2-1 Meetings

10:30

Main Plenary

Pharma BD Forum

Licensing Strategies Workshop

Clinical Strategies Workshop

1-2-1 Meetings

12:30

Lunch Break

13:30

Main Plenary

Pharma BD Forum

Regulatory Strategies Workshop

1-2-1 Meetings

15:30

Keynote Plenary

1-2-1 Meetings

Network

Biotech, medtech and deeptech CxOs will be coming to Boston and joined by investors and pharma to address key issues facing their businesses and the wider healthcare sector.

Partner

1-2-1 partnering is a key focus across the two days. Pre-event all attendees and see who is attending, message each other and book meetings to find investors, investment opportunities and connect with potential partners.

Learn

Understand the latest trends, forecasts and insights from leading investors, life science executives, pharma BD&L heads and industry KOLs through presentations and more informal workshops and group discussions.

What do 2018 attendees say?

"Learned a great deal, made important new contacts"

Jay Goth
Director, Forentis Fund

"Great panels and interesting content"

Adam Cohen
Associate, Broadview Ventures

"Very well done conference"

STRATEGY, INVESTMENT AND PARTNERING FOR LIFE SCIENCE EXECUTIVES

Key Partners

LSX World Congress USA

Confirmed Speakers

Agenda at a Glance

What do 2018 attendees say?

Jay Goth Director, Forentis Fund

Adam Cohen Associate, Broadview Ventures

Joseph Cawley CSO, Encrypgen

Jay Goth
Director, Forentis Fund

Adam Cohen
Associate, Broadview Ventures

Joseph Cawley
CSO, Encrypgen